Clinical trial
Safety Study of Vascudyne's Small Diameter Acellular Tissue Engineered Vessel (ATEV) for Coronary Artery Bypass
NCT07078370 is registered in ClinicalTrials.gov with Vascudyne, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Study of Vascudyne's Small Diameter Acellular Tissue Engineered Vessel (ATEV) for Coronary Artery Bypass
- Lead sponsor
- Vascudyne, Inc.
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- August 28, 2025
- Completion date
- July 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, multi vessel coronary artery disease